Darin Dougherty, MD
Psychiatry · Boston, MANPI 1619968286
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Livanova USA, Inc. at 32.9% of the total. Reporting peaked in 2023 at $10,994 and has fallen 82.1% since, to $1,964 in 2025. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $650.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$9K
- Medtronic$7K
- Boehringer Ingelheim$3K
- Biogen$3K
- Omniscient Neurotechnology America Ltd$2K
- Neurocrine Biosciences, Inc.$2K
- plus $1K from 3 others
Across 163 payments — averaging $1914.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$214K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$57K
- Abbott$19K
- Medtronic$13K
- AbbVie$5K
- Boehringer Ingelheim International GmbH$5K
- plus $83 from 1 others
What the payments were for
- Consulting fees$7,50028%
- Speaking & faculty fees$12,25046%
- Travel & lodging$5,39020%
- Food & beverage$1,5396%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 7 | $8,769 |
| Medtronic | 6 | $6,543 |
| Boehringer Ingelheim | 10 | $3,216 |
| Biogen | 1 | $2,658 |
| Omniscient Neurotechnology America Ltd | 2 | $2,250 |
| Neurocrine Biosciences, Inc. | 11 | $1,964 |
| AbbVie | 1 | $500 |
| Abbott | 2 | $412 |
| Immedica Pharma US, Inc. | 1 | $367 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy Symmetry Model 8103 Generator$8,769
- ACTIVA$6,424
- Quicktome$2,250
- INFINITY$403
How this compares
$26,678 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Boston
- Ximena Sanchez-SamperBoston$258K
- George PapakostasBoston$170K
- Maurizio FavaBoston$120K
- Andrew NierenbergBoston$94K
- Lee GoldsteinBoston$90K
- Gary SachsBoston$81K
- Dan IosifescuBoston$61K
- Lee CohenBoston$51K
- Michael OstacherBoston$39K
- Cristina MontalvoBoston$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.